FI974640A - Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit - Google Patents

Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit Download PDF

Info

Publication number
FI974640A
FI974640A FI974640A FI974640A FI974640A FI 974640 A FI974640 A FI 974640A FI 974640 A FI974640 A FI 974640A FI 974640 A FI974640 A FI 974640A FI 974640 A FI974640 A FI 974640A
Authority
FI
Finland
Prior art keywords
isochromanes
migraine
disubstituted
treatment
disubstituted isochromanes
Prior art date
Application number
FI974640A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI974640A0 (fi
Inventor
Michael D Ennis
Ruth E Tenbrink
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI974640A0 publication Critical patent/FI974640A0/fi
Publication of FI974640A publication Critical patent/FI974640A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI974640A 1995-06-30 1997-12-30 Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit FI974640A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74195P 1995-06-30 1995-06-30
US1123496P 1996-02-06 1996-02-06
PCT/US1996/008681 WO1997002259A1 (en) 1995-06-30 1996-06-07 1,6-disubstituted isochromans for treatment of migraine headaches

Publications (2)

Publication Number Publication Date
FI974640A0 FI974640A0 (fi) 1997-12-30
FI974640A true FI974640A (fi) 1997-12-30

Family

ID=26668092

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974640A FI974640A (fi) 1995-06-30 1997-12-30 Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit

Country Status (12)

Country Link
EP (1) EP0836599A1 (xx)
JP (1) JPH11509532A (xx)
AU (1) AU6252296A (xx)
BR (1) BR9609631A (xx)
CA (1) CA2225282A1 (xx)
CZ (1) CZ418597A3 (xx)
FI (1) FI974640A (xx)
MX (1) MX9710260A (xx)
NO (1) NO976112L (xx)
PL (1) PL324319A1 (xx)
SK (1) SK164297A3 (xx)
WO (1) WO1997002259A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
US7335660B2 (en) 2001-12-19 2008-02-26 Eli Lilly And Company Isochroman compounds for treatment of CNS disorders
GB0130339D0 (en) * 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
US7110576B2 (en) 2002-12-30 2006-09-19 Pitney Bowes Inc. System and method for authenticating a mailpiece sender
RU2372344C2 (ru) 2004-05-05 2009-11-10 Ф. Хоффманн-Ля Рош Аг Арилсульфонилбензодиоксаны, применяемые для модуляции 5-нт6 рецептора, 5-нт2a рецептора или и того, и другого
CN101119965B (zh) 2004-12-21 2012-09-26 弗·哈夫曼-拉罗切有限公司 萘满和茚满衍生物及其用途
BRPI0515830A (pt) 2004-12-21 2008-08-05 F Hoffmann La Roche derivados de cromano e usos dos mesmos no tratamento de distúrbios do sistema nervoso central
ES2306275T3 (es) 2004-12-21 2008-11-01 F. Hoffmann-La Roche Ag Derivados de cromano y sus usos como ligandos dde receptores 5-ht.
AU2005318598B2 (en) 2004-12-21 2010-08-26 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof as 5-HT antagonists
CA2591793A1 (en) 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
DE602006020351D1 (en) 2005-11-03 2011-04-07 Hoffmann La Roche Arylsulfonylchromane als 5-ht6-inhibitoren
JP2009541249A (ja) 2006-06-20 2009-11-26 エフ.ホフマン−ラ ロシュ アーゲー アリールスルホニルナフタレン誘導体およびその使用
AU2007263084A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CA2655524A1 (en) 2006-06-20 2007-12-27 F. Hoffman-La Roche Ag Arylsulfonamidyl tetralin derivatives and uses thereof
EP2404897A4 (en) * 2009-03-05 2014-02-26 Sumitomo Chemical Co PROCESS FOR PREPARING HALOGEN-SUBSTITUTED BENCHENETIMETHANOL

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
EP0737189B1 (en) * 1993-12-28 1999-07-28 PHARMACIA & UPJOHN COMPANY Heterocyclic compounds for the treatment of cns and cardiovascular disorders

Also Published As

Publication number Publication date
NO976112L (no) 1998-03-02
WO1997002259A1 (en) 1997-01-23
SK164297A3 (en) 1998-09-09
AU6252296A (en) 1997-02-05
CZ418597A3 (cs) 1998-06-17
PL324319A1 (en) 1998-05-25
CA2225282A1 (en) 1997-01-23
JPH11509532A (ja) 1999-08-24
FI974640A0 (fi) 1997-12-30
MX9710260A (es) 1998-03-29
NO976112D0 (no) 1997-12-29
BR9609631A (pt) 1999-03-02
EP0836599A1 (en) 1998-04-22

Similar Documents

Publication Publication Date Title
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
NO961483D0 (no) Fremgangsmåte for behandling av oljeholdig formasjon
DK0771789T3 (da) 1 alpha, 26-dihydroxy-D-homo-vitamin D3
ITTO950104A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
FI974640A0 (fi) Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
HUP0004085A3 (en) Novel 3,6-hemiketals from the class of 9a-azalides
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
ITTO960495A0 (it) Procedimento per accrescere il flusso per elettrotrasporto di polipep-tidi.
DE69618634T2 (de) 1,4-benzodioxin-derivate
IT1292552B1 (it) Dispositivo per l'applicazione di rivestimenti.
ITTO950099A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
NO985535L (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
IL113057A0 (en) Compositions for the treatment of dandruff
ATE220674T1 (de) 12h-dibenzo(d,g)(1,3)dioxocin derivate
HK1010095A1 (en) Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals.
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
DK0783491T3 (da) Fremgangsmåde til fremstilling af 3,3,5-trichlorglutarimid
ES1031096Y (es) Ducha antivandalica.
FI940088A0 (fi) Regleranordning/reglerdel foer spolvattenmnaengden i en vattenklosett
DK0737068T3 (da) 2,3-diaryl-1-benzopyraner til behandling af dermatitis
RU95117268A (ru) Средство для лечения атопического дерматита
ITRM940468A0 (it) "impiego di esteruretani per ls riconcia".
ITTV940061A0 (it) "pedana, particolarmente per la pratica della scherma".
FI951660A0 (fi) Foerfarande foer undersoekning av virkes fuktighet